Eikon Therapeutics, Inc.
EIKN
$10.73
$0.020.19%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 06/30/2025 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 531.18M | 512.18M | 335.98M | -- | |
| Total Receivables | -- | -- | -- | -- | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 15.40M | 16.92M | 12.54M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 400.00K | 400.00K | 400.00K | -- | |
| Total Current Assets | 546.98M | 529.50M | 348.92M | -- | |
|
|
|||||
| Total Current Assets | 546.98M | 529.50M | 348.92M | -- | |
| Net Property, Plant & Equipment | 224.21M | 229.13M | 233.86M | -- | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 8.38M | 8.36M | 11.95M | -- | |
| Total Assets | 779.57M | 850.83M | 594.73M | -- | |
|
|
|||||
| Total Accounts Payable | 6.56M | 6.01M | 681.00K | -- | |
| Total Accrued Expenses | 39.29M | 29.22M | 44.16M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 9.45M | 9.74M | 10.03M | -- | |
| Total Finance Division Other Current Liabilities | -- | 102.00K | 137.00K | -- | |
| Total Other Current Liabilities | -- | 102.00K | 137.00K | -- | |
| Total Current Liabilities | 55.30M | 45.06M | 55.01M | -- | |
|
|
|||||
| Total Current Liabilities | 55.30M | 45.06M | 55.01M | -- | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 242.77M | 245.09M | 247.29M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 15.00M | 10.00M | 10.00M | -- | |
| Total Liabilities | 313.07M | 300.16M | 312.30M | -- | |
|
|
|||||
| Common Stock & APIC | 1.56B | 1.55B | 41.48M | -- | |
| Retained Earnings | -1.09B | -1.00B | -920.51M | -- | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 466.50M | 550.67M | -879.03M | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 1.16B | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 1.16B | -- | |
|
|
|||||
| Total Common Equity | 466.50M | 550.67M | -879.03M | -- | |
| Total Preferred Equity | -- | -- | 1.16B | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 466.50M | 550.67M | 282.44M | -- | |
|
|
|||||